lamostat
Lamostat is a synthetic protease inhibitor belonging to the serine protease inhibitor class. It is structurally related to gabexate mesilate. Its primary mechanism of action involves inhibiting the activity of various serine proteases, including thrombin, plasmin, and kallikrein. This inhibition disrupts the coagulation cascade and fibrinolytic pathways.
Lamostat is primarily used medically to prevent or treat disseminated intravascular coagulation (DIC), a serious condition
The administration of lamostat is typically intravenous. The dosage and duration of treatment are determined by